NCT02446600
Clinical Trial Information
Trial Number: NCT02446600 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
Trial Title:
A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Study ID:
NRG-GY004
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02446600-D2 | This dataset contains quality of life (QOL) data from trial NCT02446600 presented in 35290101. NCT02446600-D1 contains baseline, outcome, and toxicity data. |
| NCT02446600-D1 | This dataset contains the treatment comparison data between Olaparib With or Without Cediranib and Platinum-Based Chemotherapy in trial NCT02446600. NCT02446600-D2 contains QOL/PRO data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®